Financial Data and Key Metrics Changes - MA membership grew 43% to 523,000 members, while revenue increased 52% to $1.604 billion, both metrics towards the low end of guidance ranges [5][6] - Medical margin grew 1% to $157 million, reflecting an in-quarter medical cost trend of 9.1%, which is above trends observed in Q4 2023 [6][14] - Adjusted EBITDA increased 21% to $29 million, exceeding guidance due to better flow-through of medical margin to gross profit [6][7] Business Line Data and Key Metrics Changes - The company began implementation work with five new physician groups as part of the Class of 2025, indicating strong demand for its platform among high-quality physician groups [7][16] - The decision to exit certain unprofitable payer contracts was made to refine the business model and improve profitability [5][10] Market Data and Key Metrics Changes - Paid claims data for major payers indicated elevated medical cost trends in January, which began to moderate in February [7][14] - Inpatient utilization moderated throughout the quarter, remaining relatively flat in March and declining in April [7][14] Company Strategy and Development Direction - The company is focused on refining payer relationships, expanding support for primary care doctors, improving data visibility, and enhancing operating efficiency [8][14] - The demand for value-based care is accelerating among payers and physicians, reinforcing the company's strategic position [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment with the constrained Medicare program funding environment but emphasized the unique value the company provides [14][15] - The company maintains its full-year guidance for medical margin and adjusted EBITDA, taking a cautious approach to medical cost trends [22][23] Other Important Information - The company ended the quarter with cash and marketable securities of $426 million, expecting to use $125 million to $150 million of cash during 2024 [21][22] - The ongoing search for a new CFO and CMO is progressing well, with a focus on finding the right candidates [17] Q&A Session Summary Question: Impact of cost pressures on value-based care - Management noted that the current environment is accelerating the value provided to payers and physician partners, with a focus on sustainable value-based care networks [25][26] Question: Progress on contract renegotiations - Management indicated that they are focusing on long-term relationships with payers and are pivoting to focus on 2025 contract renewals [28][30] Question: Update on older cohorts' medical margin progression - Management stated that they are on track with reducing variability and improving medical margins for older cohorts [32][33] Question: Utilization trends and cost buckets - Management observed elevated utilization in outpatient services and Part B drugs, particularly in oncology, with a cautious approach to medical cost trends [40][74] Question: Visibility on claims data and margin expectations - Management emphasized improved data visibility and ongoing dialogue with payers, providing comfort in their margin outlook despite industry challenges [42][46] Question: Mechanism of exiting unprofitable contracts - Management clarified that exits from unprofitable contracts will end financial responsibility for those members effective June 30, with expected benefits exceeding $10 million [48][49] Question: Characteristics evaluated for contract changes - Management highlighted that decisions to exit contracts were based on higher utilization and payer benefit design changes, made in concert with partners [62][64]

Financial Performance - For the quarter ended March 2024, Agilon Health reported revenue of $1.6 billion, reflecting a year-over-year increase of 41.2% [1] - The earnings per share (EPS) was $0.01, down from $0.04 in the same quarter last year [1] - The reported revenue was a slight miss of -0.85% compared to the Zacks Consensus Estimate of $1.62 billion, while the EPS exceeded the consensus estimate of -$0.02 by +150.00% [1] Key Metrics - Average Medicare Advantage membership reached 518,400, surpassing the estimated 513,855 [2] - Direct Contracting beneficiaries (ACO REACH) totaled 131,000, exceeding the average estimate of 119,150 [2] - Medicare Advantage Members were reported at 522,800, slightly below the average estimate of 527,365 [2] - Revenues from medical services were $1.60 billion, compared to the average estimate of $1.61 billion, marking a +41.1% change year over year [2] - Revenues from other operating activities were $3.16 million, significantly higher than the estimated $1.92 million, representing a +139.9% change compared to the previous year [2] Stock Performance - Agilon's shares have returned -6.8% over the past month, while the Zacks S&P 500 composite experienced a -0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0 ...

Exhibit 99.1 agilon health Reports First Quarter 2024 Results Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000 Continued progress executing performance action plan with focus on driving profitability and enhancing operating efficiency Maintaining full year 2024 guidance for Medical Margin and Adjusted EBITDA AUSTIN, T.X., May 7, 2024 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physici ...

NEW YORK, April 13, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Agilon To ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Agilon Health, Inc. (AGL) is a healthcare services company for seniors. The Zacks Consensus Estimate for its current year earnings has been revised 357.1% downward over the last 60 days.BankFinancial Corporation (BFIN) is a bank holding company for BankFinancial, National Association. The Zacks Consensus Estimate for its current year earnings has been revised 12.6% downward over the last 60 days.Sleep Number Corporation (SNBR) offers ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:agilon health, inc. (AGL) is a senior healthcare provider. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 60 days.Bel Fuse Inc. (BELFB) is a multifaceted technology solutions provider. The Zacks Consensus Estimate for its current year earnings has been revised 20.8% downward over the last 60 days.Driven Brands Holdings Inc. (DRVN) is an automotive service provider. The Zacks Co ...

agilon health, Inc. (NYSE:AGL) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Matt Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Ryan Daniels - William Blair Eduardo Ron - Truist Securities Whit Mayo - Leerink Partners Elizabeth Anderson - Evercore ISI Sean Dodge - RBC Capital Markets Stephen Baxter - Wells Fargo George ...

For the quarter ended December 2023, Agilon Health (AGL) reported revenue of $1.06 billion, up 53.1% over the same period last year. EPS came in at -$0.41, compared to -$0.14 in the year-ago quarter.The reported revenue represents a surprise of +0.72% over the Zacks Consensus Estimate of $1.05 billion. With the consensus EPS estimate being -$0.28, the EPS surprise was -46.43%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Agilon Health (AGL) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -46.43%. A quarter ago, it was expected that this senior-focused health care company would post a loss of $0.05 per share when it actually produced a loss of $0.06, delivering a surprise of -20%.Over the last four quarters, t ...